Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Kids Neuroscience Centre, |
RCV001726523 | SCV001571550 | likely pathogenic | Beta-D-mannosidosis | criteria provided, single submitter | clinical testing | Detected one abnormal splicing event, in-frame exon 4 skipping (r.379_549del). This event removes 57 amino acids from the predicted glycoside hydrolase, family 2, N-terminal domain (IPR006104), p.Ser127_Lys183del. | |
Victorian Clinical Genetics Services, |
RCV001726523 | SCV002767770 | likely pathogenic | Beta-D-mannosidosis | 2022-09-02 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Beta-mannosidosis (MIM#248510). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0210 - Splice site variant proven to affect splicing of the transcript with a known effect on protein sequence. mRNA studies confirm that this variant induces aberrant splicing resulting in an in-frame skipping of exon 4 which removes 57 amino acids from the predicted glycoside hydrolase, family 2, N-terminal domain, p.(Ser127_Lys183del) (Splicing Diagnostics Kid's Neuroscience Centre). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0311 - An alternative nucleotide change at the same canonical splice site, is present in gnomAD at a frequency of 0.00000698 (v2 & v3: 2 heterozygotes, 0 homozygotes). (I) 0601 - Variant is located in a well-established functional region (exon 4), which is considered essential because it harbours critical protein interaction domains and a known disease causing variant is present in this exon (PMID: 16904924, 18565776, 22369051, 30552791). (SP) 0705 - No comparable splice variants have previous evidence for pathogenicity. (I) 0807 - This variant has no previous evidence of pathogenicity. This variant has been regarded as likely pathogenic in ClinVar by studies performed with this family's sample (PMID: 34906502). (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign |
Fulgent Genetics, |
RCV001726523 | SCV002799999 | likely pathogenic | Beta-D-mannosidosis | 2021-07-18 | criteria provided, single submitter | clinical testing |